logo
Book a meeting
PreCyte

Pre Cyte

Biotechnology, 839 Redwood Dr, Seattle, Washington, 95542, United States, 1-10 Employees

precyte.net

  • LinkedIn

phone no Phone Number: +18*********

Who is PRECYTE

Non-invasive diagnostic tools like blood tests are needed to enable early detection of disease to save lives. But development of these tests is challenging due to very low signal to noise...

Read More

lock icon Get Full Access
map
  • 839 Redwood Dr, Seattle, Washington, 95542, United States Headquarters: 839 Redwood Dr, Seattle, Washington, 95542, United States
  • 2014 Date Founded: 2014
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5047

checked-icon Does something look wrong? Fix it. | View contact records from PRECYTE

PreCyte Org Chart and Mapping

Employees
Sherry Q

Sherry Q

Research Scientist Consultant

See Full Org Chart arrow
email-formate-icon
View Email Formats for PreCyte
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding PreCyte

Answer: PreCyte's headquarters are located at 839 Redwood Dr, Seattle, Washington, 95542, United States

Answer: PreCyte's phone number is +18*********

Answer: PreCyte's official website is https://precyte.net

Answer: PreCyte's revenue is $1 Million to $5 Million

Answer: PreCyte's SIC: 5047

Answer: PreCyte has 1-10 employees

Answer: PreCyte is in Biotechnology

Answer: PreCyte contact info: Phone number: +18********* Website: https://precyte.net

Answer: Non-invasive diagnostic tools like blood tests are needed to enable early detection of disease to save lives. But development of these tests is challenging due to very low signal to noise ratio of blood biomarkers. We are developing a tool for blood-based diagnostics to overcome this issue called the indicator cell assay platform (iCAP). The assay uses standardized cells as biosensors that detect and respond to signals in patient blood, and machine learning tools to predict the disease state of the patients from the gene expression responses of the cells. The assay transforms the challenging task of identifying and detecting very low abundance blood biomarkers of disease into the well-established practice of measuring cell culture responses in vitro. Our vision is to develop pan-cancer iCAP panels for cancer screening to improve patient outcome. We are currently developing iCAPs for the early detection of lung cancer and Alzheimer's disesae.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access